Aspen Clinical Research is currently taking part in a clinical research study for adults ages 18 through 70 with Ulcerative Colitis. In this study, researchers are evaluating the effectiveness of an investigational medication taken in combination with Mesalamine to decrease the inflammation caused by Ulcerative Colitis.
Your first visit to the research clinic will be a screening visit. During this visit you will meet with a study coordinator to fully review study details. If you decide to participate, a more in depth assessment of your health will take place to determine your final eligibility. If you are eligible and chooses to enroll, you will be required to return to our research clinic at various times for treatment and follow-up visits.
Space in the study is limited. Health insurance is not required. All clinical visits, medications, and physical exams are provided at no cost. Participants may receive compensation for time and travel. If you are unable to complete the study for any reason, you will receive a compensation amount based upon the number of visits you complete.
For more in-depth information regarding this study please click HERE.
Please complete the form below to see if you pre-qualify for the study.
Disclaimer: Not all individuals that complete the on-line questionnaire will qualify for the study. An in-depth study and medical evaluation must be completed in person in order to qualify for the study.